Zak Mir interviews Dennis Edmonds, director of Kazera Global. Click the play button below to listen to the audio.
1 – Can you elaborate more on the deal announced on Thursday regarding buying a diamond mining and Heavy Mineral Sands operation in South Africa. What is the rationale?
2 – What is the plan here with regards to cash flow generation – can shareholders expect this acquisition to be cash flow positive or is it just another “me too” cash hole that has bedeviled many, many AIM mining plays?
3 – There was a comment in the RNS regarding “Possible partner identified to build a Processing Plant on site at their own cost and to greatly improve HMS’s profit targets” – can you elaborate on this?
4 – I note that Mineral Commodities of Australia have an operation just south of where KZG is planning to mine for Heavy Mineral Sands – is it fair to say that Kazera’s HMS operations will be a “ready to go” operation once the licence is approved? Also, what time scale can shareholders expect with regards to receiving the HMS licence?
5 – In summary, can you explain why shareholders should be excited about this project?
RISK WARNING & DISCLAIMER
Kazera Global is a research client of Align Research. Align Research & a director of Align Research own shares in Kazera Global . Full details of our Company & Personal Account Dealing Policy can be found on our website http://www.alignresearch.co.uk/legal/
This is a marketing communication and cannot be considered independent research. Nothing in this report should be construed as advice, an offer, or the solicitation of an offer to buy or sell securities by us. As we have no knowledge of your individual situation and circumstances the investment(s) covered may not be suitable for you. You should not make any investment decision without consulting a fully qualified financial advisor.
Your capital is at risk by investing in securities and the income from them may fluctuate. Past performance is not necessarily a guide to future performance and forecasts are not a reliable indicator of future results. The marketability of some of the companies we cover is limited and you may have difficulty buying or selling in volume. Additionally, given the smaller capitalisation bias of our coverage, the companies we cover should be considered as high risk.
This financial promotion has been approved by Align Research Limited